|
1) 第19回川崎病全国調査成績. 子どもの病気に関する包括的データベース｢難治性疾患に関する疫学研究データベース等を含む｣の構築とその利用に関する研究2005-2007年度, 川崎病全国調査担当グループ
|
|
|
|
|
2) 高橋 啓. 川崎病冠動脈炎後遺病変の病理. 小児科診療. 2006; 69: 1017-20
|
|
|
|
|
3) Holman RC, Curns AT, Belay ED, et al. Kawasaki syndrome in Hawaii. Pediatr Infect Dis J. 2005; 24: 429-33
|
|
|
|
|
4) Kobayashi T, Inoue Y, Takeuchi K, et al. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation. 2006; 113: 2606-12
|
|
|
|
|
|
5) Inoue Y, Okada Y, Shinohara M, et al. A multicenter prospective randomized trial of corticosteroids in primary therapy for Kawasaki disease: clinical course and coronary artery outcome. J Pediatr. 2006; 149: 336-41
|
|
|
|
|
|
6) Wooditch AC, Aronoff SC. Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: a meta-analysis of 862 children. Pediatrics. 2005; 116: 989-95
|
|
|
|
|
|
7) Burns JC, Best BM, Mejias A, et al. Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease. J Pediatr. 2008. In press
|
|
|
|
|
|
8) Onouchi Y, Tamari M, Takahashi A, et al. A genomewide linkage analysis of Kawasaki disease: evidence for linkage to chromosome 12. J Hum Genet. 2007; 52: 179-90
|
|
|
|
|
|
9) Wang CL, Wu YT, Liu CA, et al. Expression of CD40 ligand on CD4＋ T-cells and platelets correlated to the coronary artery lesion and disease progress in Kawasaki disease. Pediatrics. 2003; 111: E140-7
|
|
|
|
|
|
10) Onouchi Y, Onoue S, Tamari M, et al. CD40 ligand gene and Kawasaki disease. Eur J Hum Genet. 2004; 12: 1062-8
|
|
|
|
|
|
11) Onouchi Y, Gunji T, Burns JC, et al. ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet. 2008; 40: 35-42
|
|
|
|
|
|
12) Dewaste V, Moreau C, De Smedt F, et al. The three isozymes of human Inositol-1, 4, 5-triphosphate 3-kinase show specific intracellular localization but comparable Ca2＋ responses on transfection in COS-7 cells. Biochem J. 2003; 374: 41-9
|
|
|
|
|
|
13) Nalaskowski MM, Windhorst S, Stockebrand MC, et al. Subcellular localisation of human inositol 1, 4, 5-trisphosphate 3-kinase C: species-specific use of alternative export sites for nucleo-cytoplasmic shuttling indicates divergent roles of the catalytic and N-terminal domains. Biol Chem. 2006; 387: 583-93
|
|
|
|
|
|
14) Irvine RF, Schell MJ. Back in the water: the return of the inositol phosphates. Nat Rev Mol Cell Biol. 2001; 2: 327-38
|
|
|
|
|
|
15) Macian F. NFAT proteins: key regulators of T-cell development and function. Nat Rev Immunol. 2005; 5: 472-84
|
|
|
|
|
|
16) 古川 漸, 松原知代, 市山高志. 川崎病と炎症性サイトカイン. 日本臨牀. 2008; 66: 258-64
|
|
|
|
|